Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.

Hanren Dai Zhiqiang Wu Hejin Jia Chuan Tong Yelei Guo Dongdong Ti Xiao Han Yang Liu Wenying Zhang Chunmeng Wang Yajing Zhang Meixia Chen Qingming Yang Yao Wang Weidong Han

J Hematol Oncol

Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.

Published: May 2020

An amendment to this paper has been published and can be accessed via the original article.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236305	PMC
http://dx.doi.org/10.1186/s13045-020-00878-2	DOI Listing

Publication Analysis

Top Keywords

correction bispecific

bispecific car-t

car-t cells

cells targeting

targeting cd19

cd19 cd22

cd22 therapy

therapy adults

adults relapsed

relapsed refractory

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!